Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.
Suon
Sokreine
S
Department of Neurosymptomatic Disorders, Merck Research Laboratories, West Point, PA 19486, USA. celina_zerbinatti@merck.com.
Zhao
Jie
J
Villarreal
Stephanie A
SA
Anumula
Nikesh
N
Liu
Mali
M
Carangia
Linda M
LM
Renger
John J
JJ
Zerbinatti
Celina V
CV